Clinical Trial Update: γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant [EARLY_Phase 1]

View source ↗

Summary

This entry describes an early-phase clinical trial of γδ T cell therapy to prevent relapse in high-risk acute myeloid leukemia after transplant, which is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• gamma-delta T cell therapy (gamma-delta T cells)

Snippet

Sponsor: Guangzhou Bio-gene Technology Co., Ltd | Conditions: Leukemia, Myeloid | EARLY_Phase 1 | Status: NOT_YET_RECRUITING